Vor Biopharma Inc. (VOR) Tops Q4 EPS by 7c
Vor Biopharma Inc. (NASDAQ: VOR) reported Q4 EPS of ($0.53), $0.07 better than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.
Vor Biopharma Inc. (NASDAQ: VOR) reported Q4 EPS of ($0.53), $0.07 better than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.